Detalhe da pesquisa
1.
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper.
Allergy
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700063
2.
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Ann Allergy Asthma Immunol
; 132(5): 610-622.e7, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151100
3.
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
Allergy
; 78(1): 131-140, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922152
4.
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
Allergy
; 78(11): 2835-2850, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449468
5.
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study.
Allergy
; 78(4): 968-983, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325824
6.
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.
Allergy
; 78(7): 1758-1776, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042071
7.
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Allergy
; 77(4): 1231-1244, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459002
8.
Development and validation of combined symptom-medication scores for allergic rhinitis.
Allergy
; 77(7): 2147-2162, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932829
9.
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data.
Allergy
; 77(9): 2699-2711, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258105
10.
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference.
Allergy
; 77(10): 3002-3014, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567393
11.
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms.
Clin Exp Allergy
; 51(8): 1033-1045, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880889
12.
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
Allergy
; 76(6): 1624-1628, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378789
13.
Management of anaphylaxis due to COVID-19 vaccines in the elderly.
Allergy
; 76(10): 2952-2964, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811358
14.
Spices to Control COVID-19 Symptoms: Yes, but Not Only .
Int Arch Allergy Immunol
; 182(6): 489-495, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352565
15.
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.
Int Arch Allergy Immunol
; 182(4): 324-338, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567446
16.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Lancet
; 394(10209): 1638-1650, 2019 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543428
17.
High mortality in COVID-19 patients with mild respiratory disease.
Eur J Clin Invest
; 50(9): e13314, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535885
18.
Next generation health guidelines: The role of real-life data in evidence-based medicine.
Allergy
; 79(1): 12-14, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680074
19.
The contribution of digital health to net zero patient care in allergic diseases: From concept to practice.
Allergy
; 79(2): 281-285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37712588
20.
Disease-modifying anti-asthmatic drugs.
Lancet
; 399(10335): 1664-1668, 2022 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461560